Liver Tumor Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Liver Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Liver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2 more
HistoSonics, Inc.5,000 enrolled26 locationsNCT06486454
Recruiting
Phase 1

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

CholangiocarcinomaBenign Liver TumorAdult Hepatocellular Carcinoma+2 more
M.D. Anderson Cancer Center110 enrolled1 locationNCT02379377
Recruiting

Evaluation of Resection Techniques for Pancreatic Tumors

SurgeryLiver TumorPancreas Tumor
Methodist Health System431 enrolled1 locationNCT05128890
Recruiting
Not Applicable

Needle-based Percutaneous Ablation of Liver Tumors.

HCC - Hepatocellular CarcinomaLiver TumorsMetastatic Liver Tumor
inTumo Therapeutics, Inc.31 enrolled1 locationNCT06689670
Recruiting
Not Applicable

Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection

Primary Liver CancerLiver ResectionBenign Liver Tumor+2 more
Warangkana Lapisatepun74 enrolled1 locationNCT06905015
Recruiting
Not Applicable

Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy

Liver Tumor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University220 enrolled1 locationNCT06594289
Recruiting

Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors

Liver Tumor
Xijing Hospital200 enrolled1 locationNCT06524557
Recruiting
Phase 4

The Preoperative Administration of ICG Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.

Liver Tumor; Surgery
Hospital Universitari Vall d'Hebron Research Institute173 enrolled1 locationNCT06398028